Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7173395 | 0.79 | MEN1 (0.31) | — | |
| SCHEMBL27661593 | 0.75 | — | — | |
| SCHEMBL83099 | 0.75 | CYP3A4 (0.33) | CYP3A4 | |
| SCHEMBL27659640 | 0.73 | — | — | |
| SCHEMBL29193898 | 0.72 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL10533148 | 0.69 | CYP3A4 (0.48) | CYP3A4 | |
| SCHEMBL28228911 | 0.67 | — | — | |
| SCHEMBL27456957 | 0.66 | — | — | |
| SCHEMBL22210 | 0.65 | CYP3A4 (0.62) | CYP3A4 | |
| SCHEMBL29405309 | 0.65 | CYP3A4 (0.50) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200040112-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | ROQUETTE FRERES (FR) | 2020-02-06 | — | — | US | claimed |
| EP-3601293-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | Roquette Freres (FR) | 2020-02-05 | — | — | EP | claimed |
| WO-2018178567-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | ROQUETTE FRERES (FR) | 2018-10-04 | — | — | WO | claimed |
| EP-3277693-A1 | (METH)ACRYLATE-FUNCTIONALIZED EXTENDED ISOSORBIDE | Henkel IP & Holding GmbH (DE) | 2018-02-07 | — | — | EP | claimed |
| WO-2016160135-A1 | (METH)ACRYLATE-FUNCTIONALIZED EXTENDED ISOSORBIDE | Henkel IP & Holding GmbH (DE) | 2016-10-06 | — | — | WO | claimed |
| US-20200040112-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | ROQUETTE FRERES (FR) | 2020-02-06 | — | — | US | disclosed |
| EP-3601293-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | Roquette Freres (FR) | 2020-02-05 | — | — | EP | disclosed |
| WO-2018178567-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | ROQUETTE FRERES (FR) | 2018-10-04 | — | — | WO | disclosed |
| EP-2588549-A1 | D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS | DSM IP Assets B.V. (NL) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012003106-A1 | D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2012-01-05 | — | — | WO | disclosed |
| WO-2010028996-A2 | METHOD OF FORMING A POLYURETHANE FOAM | BASF SE (DE) | 2010-03-18 | — | — | WO | disclosed |
| WO-2007001807-A1 | DIRECT THERMOGRAPHIC MATERIALS WITH CROSSLINKED CARRIER LAYER | CARESTREAM HEALTH, INC. (US) | 2007-01-04 | — | — | WO | disclosed |
| EP-0934360-A1 | POLYMER MIXTURES CONTAINING POLYDIORGANOSILOXANE UREA-CONTAINING COMPONENTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998017726-A1 | POLYMER MIXTURES CONTAINING POLYDIORGANOSILOXANE UREA-CONTAINING COMPONENTS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-04-30 | — | — | WO | disclosed |
| EP-0822951-A1 | POLYDIORGANOSILOXANE POLYUREA SEGMENTED COPOLYMERS AND A PROCESS FOR MAKING SAME | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-02-11 | — | — | EP | disclosed |
| WO-1996034029-A1 | POLYDIORGANOSILOXANE POLYUREA SEGMENTED COPOLYMERS AND A PROCESS FOR MAKING SAME | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040112-A1 | ACRYLIC DERIVATIVES OF 1,4:3,6-DIANHYDROHEXITOL | ALG1, DERA, ALG8 | CYP3A4 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.